BioSpace News Archive

Faron Pharmaceuticals Ltd announces that new biomarker data from patients treated with bexmarilimab as part of the ongoing phase I/II MATINS trial, will be presented at the upcoming American Society of Clinical Oncology 2022 Annual Meeting being held in Chicago, US from June 3 – 7.

Avivagen Inc. is pleased to announce that it has signed a new distribution agreement with Nong San Viet Co., Ltd to support the company’s continued market expansion for its oxidized carotenoid-based feed additive product in Vietnam.

Orphazyme A/S in restructuring, a late-stage biopharmaceutical company, announces that an in-court meeting was held where the restructuring proposal as published by the Company through company announcement no. 26/2022 on May 18, 2022, was approved by the Company’s creditors and affirmed by the Danish Maritime and Commercial High Court in accordance with sections 13 d and 13 e of the Danish Insolvency Act.

Hansa Biopharma AB, “Hansa”, pioneer in enzyme technology for rare immunological conditions, announces that Peter Nicklin has been proposed as new Chairman of the Board at Hansa Biopharma.

Bavarian Nordic A/S announced the signing of a number of supply contracts with undisclosed countries for the Company’s smallpox vaccine with the aim to ensure sufficient supply to meet the requirements for vaccinating individuals at risk for monkeypox in the short to medium term.

MedX Health Corp., a global leader in teledermatology, announced its financial results for the three-months ended March 31, 2022, which are also available on SEDAR.

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price of € 23 m.

Sirnaomics Ltd. announced the launch of a Phase I clinical trial of the Company’s siRNA drug candidate, STP705, in adults undergoing abdominoplasty for submental fat reduction.

Tetra Bio-Pharma Inc. a leader in cannabinoid-derived drug discovery and development is pleased to announce the appointment of Leslie Auld, H.BSc, MBA, CPA, as Chief Financial Officer and member of the Company’s executive team, effective May 30, 2022.

Covalon Technologies Ltd., an advanced medical technologies company, announced its second quarter fiscal 2022 results.